Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

NCT03349255 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Will study new T-cell construct for the same indication

Conditions

Hepatocellular Carcinoma
Liver Cancer
Liver Neoplasms
Metastatic Liver Cancer

Interventions

BIOLOGICAL: autologous ET1402L1-CART cells

Sponsor

Aeon Therapeutics (Shanghai) Co., Ltd.

Collaborators

[object Object]
[object Object]